Experimental Dermatology
Retrospective analysis of immune markers and BRAF status in melanoma patients: Implications for prognosis
Experimental Dermatology, Volume 33, Issue 5, May 2024.
Experimental Dermatology
Insight into the role of IRF7 in skin and connective tissue diseases
Experimental Dermatology, Volume 33, Issue 5, May 2024.
Experimental Dermatology
Fast freezing inhibits melanin synthesis of melanocytes by modulating the Wnt/β‐catenin signalling pathway
Experimental Dermatology, Volume 33, Issue 5, May 2024.
Experimental Dermatology
In vitro effects of wound‐dressings on key wound healing properties of dermal fibroblasts
Experimental Dermatology, Volume 33, Issue 5, May 2024.
Experimental Dermatology
Dose escalation of biologic treatment in patients with moderate‐to‐severe psoriasis in Japan
Experimental Dermatology, Volume 33, Issue 5, May 2024.
Experimental Dermatology
YAP prevents senescence of dermal fibroblast and inhibits melanogenesis via paracrine effect of DKK1
Experimental Dermatology, Volume 33, Issue 5, May 2024.
Experimental Dermatology
Hospitalization and mortality in Asian autoimmune bullous dermatosis patients: A 17‐year retrospective study
Experimental Dermatology, Volume 33, Issue 5, May 2024.
Experimental Dermatology
Combining large‐spot low‐fluence 1064‐nm and fractional 1064‐nm picosecond lasers for promoting protective melanosome autophagy via the PI3K/Akt/mTOR signalling pathway for the treatment of melasma
Experimental Dermatology, Volume 33, Issue 5, May 2024.
Experimental Dermatology
Therapeutic modulation of KIT ligand in melanocytic disorders with implications for mast cell diseases
Experimental Dermatology, Volume 33, Issue 5, May 2024.
Experimental Dermatology
CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders
Experimental Dermatology, Volume 33, Issue 5, May 2024.